Endocrine System Diseases  >>  sagopilone (BAY86-5302)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sagopilone (BAY86-5302) / Bayer
NCT00246688 / 2005-000635-15: Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer

Completed
2
63
Europe
Sagopilone (BAY86-5302 , ZK219477)
Bayer
Ovarian Neoplasms
06/07
06/07

Download Options